Jonathan Rich to Hypertension, Pulmonary
This is a "connection" page, showing publications Jonathan Rich has written about Hypertension, Pulmonary.
Connection Strength
3.682
-
Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension? Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004757.
Score: 0.460
-
Novel technologies and devices for monitoring and treating pulmonary arterial hypertension. Can J Cardiol. 2015 Apr; 31(4):478-88.
Score: 0.360
-
Clinical diagnosis of pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1820-30.
Score: 0.354
-
Counterpoint: can Doppler echocardiography estimates of pulmonary artery systolic pressures be relied upon to accurately make the diagnosis of pulmonary hypertension? No. Chest. 2013 Jun; 143(6):1536-1539.
Score: 0.320
-
Rebuttal from Dr Rich. Chest. 2013 Jun; 143(6):1540-1541.
Score: 0.320
-
Noninvasive cardiac output measurements in patients with pulmonary hypertension. Eur Respir J. 2013 Jul; 42(1):125-33.
Score: 0.307
-
QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol. 2013 Aug 10; 167(3):669-76.
Score: 0.295
-
The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012 Jan; 141(1):36-42.
Score: 0.279
-
Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest. 2011 May; 139(5):988-993.
Score: 0.265
-
The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer? Int J Clin Pract Suppl. 2009 Mar; (161):17-8.
Score: 0.238
-
Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC Heart Fail. 2024 Aug; 12(8):1328-1342.
Score: 0.172
-
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. Am J Respir Crit Care Med. 2017 06 15; 195(12):1661-1670.
Score: 0.106
-
Building the case for novel clinical trials in pulmonary arterial hypertension. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):114-23.
Score: 0.089
-
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012 Apr; 163(4):589-94.
Score: 0.074
-
Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest. 2004 Oct; 126(4):1255-61.
Score: 0.044